Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease

Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. A previous rat study revealed an ADMA lowering effect following treatment with omega-3 polyunsaturated fatty acids (n-3 PUFAs). We sought to examine if an association between plasma ADMA and risk of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgeraas, Heidi, Strand, Elin, Ringdal Pedersen, Eva, Dierkes, Jutta, Ueland, Per Magne, Seifert, Reinhard, Wilberg, Eirik Rebnord, Bohov, Pavol, Berge, Rolf K., Nilsen, Dennis W. T., Nygård, Ottar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549394/
https://www.ncbi.nlm.nih.gov/pubmed/23346455
http://dx.doi.org/10.1155/2012/201742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549394/
https://www.ncbi.nlm.nih.gov/pubmed/23346455
http://dx.doi.org/10.1155/2012/201742

Ejemplares similares